The cowpox virus-encoded homolog of the vaccinia virus complement control protein is an inflammation modulatory protein

Virology

Volumn 229, Issue 1, 1997, Pages 126-133

  Miller, Cathie G ^a   Shchelkunov, Sergei N ^b   Kotwal, Girish J ^a  

^a University of Louisville School of Medicine   (United States)

^b STATE RESEARCH CENTER OF VIROLOGY AND BIOTECHNOLOGY VECTOR   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; COWPOX VIRUS; FEMALE; IMMUNOMODULATION; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; VACCINIA VIRUS; VIROGENESIS;

ANIMALIA; COWPOX VIRUS; RODENTIA; VACCINIA; VACCINIA VIRUS; VARIOLA; VARIOLA VIRUS;

EID: 0031550773     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.8396     Document Type: Article

References (27)

1. Browne, H., Smith, G., Beck, S., and Minson, T. (1990). A complex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin. Nature 347, 770-772.
2. Buller, R. M. L., Chakrabarti, S., Moss, B., and Fredrickson, T. N. (1988). Cell proliferative response to vaccinia virus is mediated by VGF. Virology 164, 182-192.
3. Buller, R. M. L., and Palumbo, G. J. (1991). Poxvirus pathogenesis. Microbiol. Rev. 55, 80-122.
4. Cooper, N. R. (1991). Complement evasion strategies of microorganisms. Immunol. Today 12, 327-331.
5. Dieli, F., Lio, D., Sireci, G., and Salerno, A. (1988). Genetic control of C3 production by the S region of the mouse MHC. J. Immunogenet. 15, 339-343.
6. Falkner, F. G., and Moss, B. (1988). Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors. J. Virol. 62, 1849-1854.
7. Isaacs, S. N., Kotwal, G. J., and Moss, B. (1992). Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc. Natl. Acad. Sci. USA 89, 628-632.
8. Kotwal, G. J., Hugin, A. W., and Moss, B. (1989). Mapping and insertional mutagenesis of a vaccinia virus gene encoding a 13,800-Da secreted protein. Virology 282, 689-698.
9. Kotwal, G. J., Isaacs, S. N., McKenzie, R., Frank, M. M., and Moss, B. (1990). Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 250, 827-830.
10. Kotwal, G. J. (1994). Purification of virokines using ultrafiltration. Am. Biotech. Lab. 12(10), 76-77.
11. Kotwal, G. J. (1996). The great escape: immune evasion by pathogens. Immunologist 4/5, 157-164.
12. Kotwal, G. J., and Moss, B. (1988). Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins. Nature 335, 176-178.
13. Kotwal, G. J., and Moss, B. (1989). Vaccinia virus encodes two proteins that are structurally related to members of the plasma serine protease inhibitor superfamily. J. Virol. 63, 600-696.
14. Krych, M., Atkinson, J. P., and Holers, V. M. (1992). Complement receptors. Curr. Opin. Immunol. 4, 8-13.
15. Maniatis, T., Fritsch, E., and Sambrook, J. (1990). "Molecular Cloning: A Laboratory Manual." Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
16. Massung, R. F., Esposito, J. J., Liu, L., Qi, J., Utterback, T. R., Knight, J. C., Aubin, L., Yuran, T. E., Parsons, J. M., Loparev, V. N., Selivanov, N. A., Cavallaro, K. F., Kerlavage, A. R., Mahy, B. W. J., and Venter, J. C. (1993). Potential virulence determinants in terminal regions of variola smallpox virus genome. Nature 366, 748-751.
17. Maxam, A., and Gilbert, W. (1980). Sequencing end-labeled DNA base-specific chemical cleavages. Methods Enzymol. 65, 499-560.
18. McKenzie, R., Kotwal, G. J., Moss, B., Hammer, C. H., and Frank, M. M. (1992). Regulation of complement activity by vaccinia virus complement-control protein. J. Infect. Dis. 166, 1245-1250.
19. Miller, C. G., Justus, D. E., Jayaraman, S., and Kotwal, G. J. (1995). Severe and prolonged inflammatory response to localized cowpox virus infection in footpads of C5-Deficient mice: Investigation of the role of host complement in poxvirus pathogenesis. Cell. Immunol. 162, 326-332.
20. Palumbo, G. J., Buller, R. M. L., and Glasgow, W. C. (1994). Multigenic evasion of inflammation by poxviruses. J. Virol. 68(3), 1737-1749.
21. Ray, C. A., Black, R. A., Kronheim, S. R., Greenstreet, T. A., Sleath, P. R., Salvesen, G. S., and Pickup, D. J. (1992). Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1b converting enzyme. Cell 69, 597-694.
22. Reid, K. B. M. (1995). The complement system: A major effector mechanism in humoral immunity. Immunologist 3, 206-211.
23. Shchelkunov, S. N., Blinov, V. M., Totmenin, A. V., Marennikova, S. S., Kolykhalov, A. A., Frolov, I. V., Chizhikov, V. E., Gutorov, V. V., Gashnikov, P. V., Belanov, E. F., Belavin, P. A., Resenchuk, S. M., Andzhaparidze, O. G., and Sandakhchiev, L. S. (1993). Nucleotide sequence analysis of variola virus Hindll M, L, I, genome fragments. Virus Res. 27, 25-35.
24. Spriggs, M. K., Armitage, R. J., Comeau, M. R., Strockbine, L., Farrah, T., McDuf, B., Ulrich, D., Alderson, M. R., Mullberg, J., and Cohen, J. I. (1996). The extracellular domain of the Epstein-Barr Virus BZLF2 protein binds the HLA-DRb chain and inhibits antigen presentation. J. Virol. 70, 5557-5563.
25. Upton, C., Mossman, K., and McFadden, G. (1992). Encoding of a homolog of the IFN-y receptor by myxoma virus. Science 258, 1369-1372.
26. Weisman, H. F., Bartow, T., Leppo, M. K., Marsh, H. C., Jr., Carson, G. R., Concino, M. F., Boyle, M. P., Roux, K. H., Weisfeldt, M. L., and Fearon, D. T. (1990). Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249, 146-151.
27. Wetsel, R. A., Fleischer, D. T., and Haviland, D. L. (1990). Deficiency of the murine fifth complement component (C5). J. Biol. Chem. 265, 2435-2440.